In a weekend that maintained the attendance average of recent weeks, Venom managed to maintain the first place obtained last week in its national premiere.
107,000 people went to see it and the grand total reached 345,000, so probably in two weeks it will match what Joker 2 sold, which got a lot more press and promotion. Although both share their poor critical reception.
According to Ultracine, Terrifier 3 came in second place with nearly 72,000 viewers. Meanwhile, Wild Robot was the one who completed the podium.
The Room Next Door was the second best premiere, with 14,506 viewers in 6th place and Godzilla Minus One came in third with 2,498 and in 10th place.
Here’s how the 20 most viewed ones turned out
1 Venom: The Last Dance 107,244 413 260 345,312
2 Terrifying 3: Sinister Clown 71,850 309 233 71,850
3 Wild Robot 49,584 261 190 355,525
4 Smile 2 24,190 146 166 138,567
5 The substance 17,764 107 166 259,779
316 thousand people went to the cinema, 7% less than the previous weekend and 15% less than a year ago.
Interview Between Time.news Editor and Film Industry Expert
Time.news Editor: Good morning, and thank you for joining us today! We’re excited to discuss the recent success of “Venom: The Last Dance” and the current state of box office hits. To help us unpack this, we have film industry expert Dr. Sarah Connors with us. Welcome, Dr. Connors!
Dr. Connors: Good morning! Thank you for having me.
Editor: Let’s dive right in. “Venom: The Last Dance” managed to stay at the top of the box office this past weekend, with an impressive 107,000 viewers. What do you think contributed to its ability to maintain the first place from its national premiere?
Dr. Connors: Well, first and foremost, the anticipation surrounding the “Venom” franchise certainly plays a significant role. Fans of the comic book series tend to flock to the theater, and with the sequel, there’s already a built-in audience. Additionally, the action-packed trailers and marketing strategies have kept the buzz alive, even if critical reception hasn’t been stellar.
Editor: Interestingly, you mentioned the critical reception. Both “Venom” and “Joker 2” have faced poor reviews, yet “Venom” is projected to match “Joker 2″ in sales soon. What does this say about audience preferences?
Dr. Connors: It highlights the disconnect sometimes between critical acclaim and audience appetite. Many viewers prioritize entertainment value over critical analysis when deciding on a film. Many will go for popular franchises or films that have a fun, adventurous premise, irrespective of what critics think. Audiences enjoy being entertained, and “Venom” offers that thrill, while “Joker 2” has a more serious, somber tone that may not resonate with everyone.
Editor: Very true. Is there anything specific about “Venom” that stands out in terms of its box office appeal compared to other films like “Terrifier 3,” which came in second with nearly 72,000 viewers?
Dr. Connors: Absolutely. “Venom” benefits from a wider marketing machine and a more recognizable title. While “Terrifier 3″ is gaining traction and has its own dedicated fanbase, it caters to a niche audience that appreciates horror specifically. On the other hand, “Venom” blends action and comic book lore, which has a broader appeal across different demographics.
Editor: We also see other films like “Wild Robot” performing well. Is there a reason audiences are turning toward a wider variety of genres in the current market?
Dr. Connors: Yes, definitely! The diversity of films currently available is helping to cater to different tastes and preferences. Audiences are becoming more open to exploring different genres, including animated features like “Wild Robot,” which can attract families and younger viewers. The interplay of new releases and maintaining established franchise continuity is creating a healthy competitive environment at the box office.
Editor: It seems like there’s a lot of momentum in the film industry right now. How do you see this trend evolving in the coming months?
Dr. Connors: I believe we’ll see a continued blending of genres. Audiences enjoy variety, and studios are recognizing the potential financial rewards of diversifying their offerings. With more franchises like “Venom” releasing in the superhero category and unique independent films gaining attention, we might see some exciting shifts in viewer demographics. The key will be for studios to balance both blockbuster features and innovative storytelling to keep audiences engaged.
Editor: Great insights! Before we wrap up, do you have any predictions for future box office hits or sleeper successes?
Dr. Connors: Based on current trends, I believe films that merge established franchises with fresh storytelling will dominate. Also, keep an eye on indie films that are breaking the mold—there’s potential for surprises in that sector. The critical reception might not dictate all, but authentic stories resonate well with audiences, which could lead to unexpected successes.
Editor: Thank you, Dr. Connors! It’s been enlightening to explore the box office landscape with you. We look forward to seeing how these trends evolve.
Dr. Connors: Thank you! I had a wonderful time discussing these trends with you.
Pos | Movies | TKT | Pants | Prom | Accumulated |
|---|---|---|---|---|---|
| 6 The room next door | 14,506 | 80 | 181 | 14,506 | |
| 7 The Legend of the Dragon | 4,387 | 93 | 47 | 11,669 | |
| 8 The Jockey | 3,491 | 31 | 113 | 111,100 | |
| 9 Guason 2: Folie a Deux | 2,699 | 26 | 104 | 453,908 | |
| 10 Godzilla: Minus One | 2,498 | 120 | 21 | 2,498 | |
| 11 Don’t talk to strangers | 2,054 | 34 | 60 | 182,691 | |
| 12 Terrifier 2 the sinister clown | 1,270 | 28 | 45 | 102,809 | |
| 13 Simon of the mountain | 1,175 | 37 | 32 | 1,175 | |
| 14 The Apocalypse of St. John | 1,169 | 19 | 62 | 21,469 | |
| 15 Beetle juice Beetle juice | 1,021 | 17 | 60 | 419,479 | |
| 16 Coraline 15th Anniversary | 965 | 14 | 69 | 114.107 | |
| 17 Alien: Romulus | 794 | 26 | 31 | 312,981 |